PHGDH and hepatocellular carcinoma: From an unbiased genome-wide CRISPR/Cas9 KO library screening coupled with transcriptome sequencing, we identified the SSP as the most important pathway responsible for TKI resistance in HCC and we demonstrated that PHGDH inhibitor targeting the first enzyme of SSP sensitized HCC cells to TKI treatment.